PA8.DE CHMP opinion: Thursday, July 23, 2026
Variation type II · Xerava · Update of section 5.1 of the SmPC in order to update the list of pathogens susceptible to eravacycline, based on the final results from study NC-IHMA-2018-01, listed as a category 3 study in the RMP; this is a surveillance study of the activity of eravacycline against ba
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.